Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Regenerative Medicine Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Regenerative Medicine Market

5.1. Covid-19: Regenerative Medicine Industry Impact
5.2. Regenerative Medicine Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Regenerative Medicine Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Regenerative Medicine Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Regenerative Medicine Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing prevalence of chronic ailments
6.1.1.2. Growing incidence of genetic disorders
6.1.2. Market Restraints
6.1.2.1. High cost of treatment
6.1.2.2. Lack of skilled manpower
6.1.3. Market Opportunities
6.1.3.1. Increasing investment in research and development
6.1.3.2. Strong product pipeline

Chapter 7. Global Regenerative Medicine Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Regenerative Medicine Market Revenue by Market Players (2019 -2019)
7.1.1.2. Regenerative Medicine Market Revenue Market Share by Market Players (2019 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Regenerative Medicine Market, By Product

8.1. Regenerative Medicine Market, by Product, 2019-2030
8.1.1. Gene Therapies
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Cell Therapies
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Tissue-Engineering
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Progenitor and Stem Cell Therapies
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Regenerative Medicine Market, By Application

9.1. Regenerative Medicine Market, by Application, 2019-2030
9.1.1. Wound Care
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Musculoskeletal
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Ophthalmology
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Oncology
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Cardiovascular
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Regenerative Medicine Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Product (2019-2030)
10.1.2. Market Revenue Forecast by Application(2019-2030)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2019-2030)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2019-2030)
10.2. Europe
10.2.1. Market Revenue Forecast by Product (2019-2030)
10.2.2. Market Revenue Forecast by Application (2019-2030)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2019-2030)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2019-2030)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2019-2030)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2019-2030)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product (2019-2030)
10.3.2. Market Revenue Forecast by Application (2019-2030)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2019-2030)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2019-2030)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2019-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2019-2030)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product (2019-2030)
10.4.2. Market Revenue Forecast by Application (2019-2030)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2019-2030)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2019-2030)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product (2019-2030)
10.5.2. Market Revenue Forecast by Application (2019-2030)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2019-2030)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2019-2030)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2019-2030)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2019-2030)

Chapter 11. Company Profiles

11.1. Integra LifeSciences Corporation
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. ProductDetails, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2015-2020)
11.1.4. Recent Developments and Strategies
11.2. Aspect Biosystems
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2015-2020)
11.2.4. Recent Developments and Strategies
11.3. Amgen, Inc.
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2015-2020)
11.3.4. Recent Developments and Strategies
11.4. Medtronic plc
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2015-2020)
11.4.4. Recent Developments and Strategies
11.5. AstraZeneca
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2015-2020)
11.5.4. Recent Developments and Strategies
11.6. Novartis AG
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2015-2020)
11.6.4. Recent Developments and Strategies
11.7. Smith & Nephew plc
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2015-2020)
11.7.4. Recent Developments and Strategies
11.8. MiMedx Group
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2015-2020)
11.8.4. Recent Developments and Strategies
11.9. Shenzhen SibionoGeneTech Co., Ltd.
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2015-2020)
11.9.4. Recent Developments and Strategies
11.10. Baxter
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2015-2020)
11.10.4. Recent Developments and Strategies

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms